CHIMERA PEPTIDES: A NOVEL THERAPEUTIC FRONTIER

The new medical frontier concerns chimera chains. Such synthetic compounds merge segments from various peptide sources, facilitating for unique pharmacological properties. The approach offers the significant opportunity to discover targeted drugs with enhanced potency or reduced adverse reactions